Literature DB >> 16318822

The impact of residual symptoms on outcome of major depression.

Noel Kennedy1, Kevin Foy.   

Abstract

Unipolar depression should be viewed as a chronic illness with multiple phases rather than as a relapsing-remitting disorder. Incomplete remission from depression is common, with approximately one third of patients continuing to have residual depression at remission. Patients who have had a depressive episode spend more time with residual depressive symptoms than with major depression long term. The presence of residual symptomatology after an episode of depression is associated with an increased risk of short-term relapse, a long-term chronic course, higher risk of suicide attempts, poor social functioning, and poor outcome of comorbid medical illnesses.

Entities:  

Mesh:

Year:  2005        PMID: 16318822     DOI: 10.1007/s11920-005-0065-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   8.081


  47 in total

1.  Psychosocial disability during the long-term course of unipolar major depressive disorder.

Authors:  L L Judd; H S Akiskal; P J Zeller; M Paulus; A C Leon; J D Maser; J Endicott; W Coryell; J L Kunovac; T I Mueller; J P Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  2000-04

2.  Subsyndromal depression: prevalence, use of health services and quality of life in an Australian population.

Authors:  Robert D Goldney; Laura J Fisher; Eleonora Dal Grande; Anne W Taylor
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-04       Impact factor: 4.328

3.  Three- to 5-year prospective follow-up of outcome in major depression.

Authors:  L Van Londen; R P Molenaar; J G Goekoop; A H Zwinderman; H G Rooijmans
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  1998-08

5.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

Authors:  E Frank; R F Prien; R B Jarrett; M B Keller; D J Kupfer; P W Lavori; A J Rush; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1991-09

6.  Bipolar II illness: course and outcome over a five-year period.

Authors:  W Coryell; M Keller; J Endicott; N Andreasen; P Clayton; R Hirschfeld
Journal:  Psychol Med       Date:  1989-02       Impact factor: 7.723

7.  Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

8.  Relapse of major depression after complete and partial remission during a 2-year follow-up.

Authors:  Luis Pintor; Cristobal Gastó; Victor Navarro; Xavier Torres; Lourdes Fañanas
Journal:  J Affect Disord       Date:  2003-02       Impact factor: 4.839

9.  Depression following myocardial infarction. Impact on 6-month survival.

Authors:  N Frasure-Smith; F Lespérance; M Talajic
Journal:  JAMA       Date:  1993-10-20       Impact factor: 56.272

10.  Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.

Authors:  M B Keller; P W Lavori; T I Mueller; J Endicott; W Coryell; R M Hirschfeld; T Shea
Journal:  Arch Gen Psychiatry       Date:  1992-10
View more
  6 in total

1.  The hidden health burden of environmental degradation: disease comorbidities and dryland salinity.

Authors:  Peter C Speldewinde; Angus Cook; Peter Davies; Philip Weinstein
Journal:  Ecohealth       Date:  2011-05-21       Impact factor: 3.184

2.  Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal study.

Authors:  J E Verhoeven; D Révész; M Picard; E E Epel; O M Wolkowitz; K A Matthews; B W J H Penninx; E Puterman
Journal:  Mol Psychiatry       Date:  2017-03-28       Impact factor: 15.992

Review 3.  Vagal Nerve Stimulation for Treatment-Resistant Depression.

Authors:  Flavia R Carreno; Alan Frazer
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 4.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

5.  Preventing recurrent depression: long-term treatment for major depressive disorder.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

6.  Regional brain functions in the resting state indicative of potential differences between depression and chronic pain.

Authors:  Atsuo Yoshino; Yasumasa Okamoto; Mitsuru Doi; Naofumi Otsuru; Go Okada; Masahiro Takamura; Naho Ichikawa; Satoshi Yokoyama; Hidehisa Yamashita; Shigeto Yamawaki
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.